The Department of Health and Human Services, specifically the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC), are seeking proposals for the development of bacteriophage for the treatment of mycobacterial infections. The goal is to address the urgent need for new therapeutics for pulmonary diseases caused by mycobacteria, including tuberculosis and pulmonary infections caused by non-tuberculous mycobacterium species. The solicitation is open to Fast-Track proposals, with a total of 2-3 anticipated awards. The budget for Phase I is $300,000 for up to one year, and for Phase II is $1,500,000 for up to 3 years. The deadline for proposal submission is November 14, 2023. For more information, visit the SBIR topic link here and the solicitation agency URL here.